Skip to main content

Table 1 Clinical features of type 2 diabetes and control groups

From: Lack of association of colonic epithelium telomere length and oxidative DNA damage in Type 2 diabetes under good metabolic control

 

Control subjects

Type 2 diabetes

P

N

22

10

 

Age (years)

61.5 ± 5.5

62.2 ± 7.5

P = 0.76

M:F

15:7

8:2

 

Diabetes duration (years)

-

6.5 (7.75)

 

BMI (kg/m2)

26.6 ± 4.5

28.1 ± 6.9

P = 0.46

HbA1c (%)

-

6.9 ± 0.7

 

Systolic blood pressure(mmHg)

145.8 ± 21.8

144.7 ± 16.9

P = 0.88

Diastolic blood pressure(mmHg)

89.6 ± 11.3

80.1 ± 9.3

P = 0.03

Statin use (n)

5

9

P = 0.0005

ACE inhibitors (n)

2

4

P = 0.05

Aspirin (n)

3

6

P = 0.01

  1. Data are means ± SD or median (interquartile range).
  2. BMI – body Mass Index
  3. HbA1c – glycosylated hemoglobin